Featured Videos |view more
MUSC surgeon Ramsay Camp, M.D., discusses HIPEC for patients with cancer within the peritoneum, which is hard to treat with intravenous chemotherapy.
Alexander Vandergrift, M.D., a neurosurgeon at MUSC, describes removing a nonfunctioning pituitary tumor from a patient through endonasal resection using an endoscope.
Although technically challenging, robotic abdominoperineal resection (APR) with robotic harvest of the rectus abdominus muscular flap can eliminate the need for a midline laparotomy, reduce wound infection rates and lead to faster recovery.
Featured Articles and Documents |view more
Removing toxic chemotherapeutic drugs from blood after cancer treatment prevents them from reaching the heart
A bench-to-bedside-pioneered lung cancer immunotherapy developed at MUSC Hollings Cancer Center will be included in one of the largest lung cancer clinical trials being offered by the National Cancer Institute.
The Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer research program in South Carolina. The cancer center comprises more than 120 faculty cancer scientists with an annual research funding portfolio of $44 million and a dedication to reducing the cancer burden in South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped for the full range of cancer care, including more than 200 clinical trials.